From January 1984 to January 2009, 144 patients underwent radical nephrectomy and inferior vena caval tumor thrombectomy, 56 (39 % ) using CPB and 88 (61 % ) HCA. Compared with HCA patients, CPB patients were of similar age (62 ¡À 10 vs 60 ¡À 11 years, P?=?.4) and gender (39 % vs 39 % female, P > .9), with similar stroke history (3.6 % vs 2.3 % , P =.6), but had less pulmonary disease (18 % vs 33 % , P?=?.06) and lower preoperative creatinine concentration (1.3 ¡À 0.72 vs 1.5 ¡À 0.86 mg ¡¤ dL?1, P?=?.04).
Complete tumor removal was achieved in all patients by both strategies. Compared with HCA procedures, CPB times were shorter (50 ¡À 33 vs 94 ¡À 40 minutes, P?<?.0001). CPB patients required fewer blood transfusions (36 % no transfusion vs 17 % , and 45 % ¡Ý4 units vs 72 % ; P?=?.003) and had no statistical difference in morbidity, including reoperation for bleeding (3.8 % vs 8.0 % , P?=?.3), renal failure requiring dialysis (3.6 % vs 10 % , P?=?.14), respiratory insufficiency (21 % vs 19 % , P?=?.8), sepsis (5.4 % vs 10 % , P?=?.3), stroke (5.4 % vs 1.1 % , P?=?.13), and in-hospital mortality (7.1 % vs 13 % , P?=?.3). Ten-year survival (22 % vs 22 % , P > .9) and freedom from cancer recurrence (24 % vs 28 % , P?=?.8) were similar.
Radical nephrectomy and removal of inferior vena caval tumor-thrombus can be simply, effectively, and safely performed with beating-heart CPB, avoiding the deleterious effects of HCA and providing clinical benefit without increasing morbidity or mortality.